ABOS Earnings

Quarterly EPS
$-0.50
Q3 2024
$-0.62
Q4 2024
$-0.48
Q1 2025
$-0.68
Q2 2025
$-0.44
Q3 2025
$-0.41
Q4 2025
$-0.33
Q1 2026
$-0.45
Q2 2026
Latest RevenueN/A
Latest Net Income-32718000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.450-32718000+33.8%
Q1 2026-$0.330-20737000+31.2%
Q4 2025-$0.410-25138000+33.9%
Q3 2025-$0.440-26451000+12.0%
Q2 2025-$0.680-40950000-100.0%
Q1 2025-$0.480-28796000-92.0%
Q4 2024-$0.620-37154000-121.4%
Q3 2024-$0.500-29765000-108.3%
Q2 2024-$0.340-20537000
Q1 2024-$0.250-14873000
Q4 2023-$0.280-16497000
Q3 2023-$0.240-12957000
Acumen Pharmaceuticals (ABOS) — Earnings